Med Ad News spoke with Christian Heidbreder, Ph.D., Chief Scientific Officer of Indivior Inc., about some of the barriers to patients seeking treatment for opioid use disorder, how to integrate treatment for opioid use disorder and infectious disease services, and the company’s efforts to provide treatments for those struggling with the disorder.
An international team of researchers led by the University of Manchester developed a new antiviral using natural glucose derivatives called cyclodextrins – a type of sugar – which shows promise in treating a broad range of viruses including herpes simplex, respiratory syncytial virus, hepatitis C, HIV and Zika virus.
Infections from China’s coronavirus spread to more than 8,100 people globally, surpassing the 2002-2003 SARS epidemic’s total in a fast-spreading health crisis forecast to pummel the world’s second-largest economy.
The Trump administration has resolved an internal dispute over how to handle new variants of fentanyl that it believes can beef up the fight against the deadly synthetic painkiller without hindering research to ease the opioid crisis, according to a draft agreement seen by Reuters.
John Kapoor, the founder and former chief executive officer of Insys Therapeutics, was sentenced to more than five years in federal prison for the role his company played in the opioid epidemic.
The toll from a new virus in China rose to six deaths and more than 300 cases as millions of Chinese prepared to travel for the Lunar New Year, heightening contagion risks.
Nektar Therapeutics withdrew the application for the company’s opioid painkiller for adults with chronic low back pain, after a U.S. Food and Drug Administration panel unanimously voted against the drug’s approval.
FreshBlood Group’s Bob Finkel shares his thoughts on various industry topics including the youth vaping epidemic and the complexities in promoting CBD-based products.
Insights into former president Richard Sackler’s control of Purdue Pharma and his aggressive stance on marketing OxyContin were revealed when internal company documents were unsealed following a four-year court battle in Kentucky.
Dr. Reb Close and Susan Burnell, MSN RN, CEN, share proven actionable strategies for tracking and addressing prescription opioid abuse both individually and collectively with other providers in this free webinar.
